GeoComply, one of the major players in the sports betting space in North America and a provider of anti-fraud and geolocation services, announced that it is further streamlining its operations, positioning the company for further growth by specifically reducing its headcount.
GeoComply embarks on streamlining its operations to spur sustainable growth
The move will affect, as the company puts it, fewer than 80 employees globally, as per a spokesperson who was quoted by Sportico, with GeoComply enacting the layoffs at a time of growing competition from companies such as Xpoint and Radar, which have emerged as viable alternatives to its products. GeoComply briefly tried to block Xpoint from offering specific services, citing its own patents, but a federal appeals court judge upheld a district courtβs decision and dismissed the argument as too broad and dismissed the grounds for blocking competitors. Despite this setback, GeoComply is believed to work with the main sports betting companies in North America, and the United States specifically. GeoComplyβs clients hold as much as 90% of the market share, as per a Wall Street Journal article in 2023. Among the companyβs partners are such household sector names as BetMGM, DraftKings, and FanDuel. GeoComply may now be reducing as much as 18% of its workforce, which stood at 450 people globally prior to the announcement.
Keeping pace with regulatory and technological changes
However, it is not about changing the companyβs size, a GeoComply spokesperson told Sportico, insisting that the firm was simply streamlining to keep pace with the rapid shifts in the regulatory and tech landscape, mentioning the advancement of AI as well. GeoComply remains in a strong position for long-term growth, and these steps ensure we remain at the forefront of the industries we operate in, the company further added. GeoComply has offices in multiple locations around the world, including Seattle, Vancouver, Montreal, New York, Las Vegas, as well as in Vietnam and Warsaw, Poland.
Comments
No comments yet.